Alterations in glucose metabolism on cognition: A possible link between diabetes and dementia

Rodrigo E. González-Reyes, Gjumrakch Aliev, Marco Ávila-Rodrigues, George E. Barreto

Resultado de la investigación: Contribución a RevistaArtículo

32 Citas (Scopus)

Resumen

The use of the carbohydrate glucose as an energetic source is essential for an adequate function of the human body. The complex regulation of this molecule involves the coordinated action of various organs such as pancreas, liver and brain. Any disruption of this physiological balance may result in a dangerous compromise of general metabolic activities increasing the possibility of developing T1DM, T2DM and possibly AD. Astrocytes convert glucose into lactate and transfer it to neurons. This lactate is essential for neuronal metabolism and for various processes including the formation of synapses, dendrites and the expression of genes involved in memory. The brain is highly susceptible to variations in glucose blood levels, and both hypoglycemia and hyperglycemia can be dangerous. Pathological hyperglycemia induces changes in plasmatic osmotic pressure, mitochondrial production of free radicals, oxidative stress and activation of neuronal apoptosis, among others. Both AD and diabetes are chronic diseases having age as an important risk factor. As the brain ages, it seems to become much more susceptible to cellular damage induced by excess of circulating glucose and this could explain the appearance of cognitive changes observed in some patients with diabetes. Excessive circulation of pro-inflammatory agents has been observed in insulin resistance and is likely that some of these mediators may cross the bloodbrain barrier and induce abnormal neuroinflammation. GSK-3 is overexpressed in diabetes and also has been reported to regulate tau phosphorylation and production of A peptides in the brain. Currently, diabetes (hyperglycemia) is considered as a risk factor for the de- velopment of AD. A novel therapeutic approach, using intranasal insulin and anti-diabetic medications in patients suffering from AD is being explored and is discussed in this review.

Idioma originalEnglish (US)
Páginas (desde-hasta)812-818
Número de páginas7
PublicaciónCurrent Pharmaceutical Design
Volumen22
N.º7
EstadoPublished - feb 1 2016
Publicado de forma externa

Huella dactilar

Cognition
Dementia
Hyperglycemia
Glucose
Brain
Lactic Acid
Glycogen Synthase Kinase 3
Osmotic Pressure
Dendrites
Human Body
Hypoglycemia
Astrocytes
Synapses
Free Radicals
Insulin Resistance
Blood Glucose
Pancreas
Oxidative Stress
Chronic Disease
Phosphorylation

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Drug Discovery

Citar esto

González-Reyes, Rodrigo E. ; Aliev, Gjumrakch ; Ávila-Rodrigues, Marco ; Barreto, George E. / Alterations in glucose metabolism on cognition : A possible link between diabetes and dementia. En: Current Pharmaceutical Design. 2016 ; Vol. 22, N.º 7. pp. 812-818.
@article{fe7546f239684077b532e189ae5f4fbb,
title = "Alterations in glucose metabolism on cognition: A possible link between diabetes and dementia",
abstract = "The use of the carbohydrate glucose as an energetic source is essential for an adequate function of the human body. The complex regulation of this molecule involves the coordinated action of various organs such as pancreas, liver and brain. Any disruption of this physiological balance may result in a dangerous compromise of general metabolic activities increasing the possibility of developing T1DM, T2DM and possibly AD. Astrocytes convert glucose into lactate and transfer it to neurons. This lactate is essential for neuronal metabolism and for various processes including the formation of synapses, dendrites and the expression of genes involved in memory. The brain is highly susceptible to variations in glucose blood levels, and both hypoglycemia and hyperglycemia can be dangerous. Pathological hyperglycemia induces changes in plasmatic osmotic pressure, mitochondrial production of free radicals, oxidative stress and activation of neuronal apoptosis, among others. Both AD and diabetes are chronic diseases having age as an important risk factor. As the brain ages, it seems to become much more susceptible to cellular damage induced by excess of circulating glucose and this could explain the appearance of cognitive changes observed in some patients with diabetes. Excessive circulation of pro-inflammatory agents has been observed in insulin resistance and is likely that some of these mediators may cross the bloodbrain barrier and induce abnormal neuroinflammation. GSK-3 is overexpressed in diabetes and also has been reported to regulate tau phosphorylation and production of A peptides in the brain. Currently, diabetes (hyperglycemia) is considered as a risk factor for the de- velopment of AD. A novel therapeutic approach, using intranasal insulin and anti-diabetic medications in patients suffering from AD is being explored and is discussed in this review.",
author = "Gonz{\'a}lez-Reyes, {Rodrigo E.} and Gjumrakch Aliev and Marco {\'A}vila-Rodrigues and Barreto, {George E.}",
year = "2016",
month = "2",
day = "1",
language = "English (US)",
volume = "22",
pages = "812--818",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "7",

}

Alterations in glucose metabolism on cognition : A possible link between diabetes and dementia. / González-Reyes, Rodrigo E.; Aliev, Gjumrakch; Ávila-Rodrigues, Marco; Barreto, George E.

En: Current Pharmaceutical Design, Vol. 22, N.º 7, 01.02.2016, p. 812-818.

Resultado de la investigación: Contribución a RevistaArtículo

TY - JOUR

T1 - Alterations in glucose metabolism on cognition

T2 - A possible link between diabetes and dementia

AU - González-Reyes, Rodrigo E.

AU - Aliev, Gjumrakch

AU - Ávila-Rodrigues, Marco

AU - Barreto, George E.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - The use of the carbohydrate glucose as an energetic source is essential for an adequate function of the human body. The complex regulation of this molecule involves the coordinated action of various organs such as pancreas, liver and brain. Any disruption of this physiological balance may result in a dangerous compromise of general metabolic activities increasing the possibility of developing T1DM, T2DM and possibly AD. Astrocytes convert glucose into lactate and transfer it to neurons. This lactate is essential for neuronal metabolism and for various processes including the formation of synapses, dendrites and the expression of genes involved in memory. The brain is highly susceptible to variations in glucose blood levels, and both hypoglycemia and hyperglycemia can be dangerous. Pathological hyperglycemia induces changes in plasmatic osmotic pressure, mitochondrial production of free radicals, oxidative stress and activation of neuronal apoptosis, among others. Both AD and diabetes are chronic diseases having age as an important risk factor. As the brain ages, it seems to become much more susceptible to cellular damage induced by excess of circulating glucose and this could explain the appearance of cognitive changes observed in some patients with diabetes. Excessive circulation of pro-inflammatory agents has been observed in insulin resistance and is likely that some of these mediators may cross the bloodbrain barrier and induce abnormal neuroinflammation. GSK-3 is overexpressed in diabetes and also has been reported to regulate tau phosphorylation and production of A peptides in the brain. Currently, diabetes (hyperglycemia) is considered as a risk factor for the de- velopment of AD. A novel therapeutic approach, using intranasal insulin and anti-diabetic medications in patients suffering from AD is being explored and is discussed in this review.

AB - The use of the carbohydrate glucose as an energetic source is essential for an adequate function of the human body. The complex regulation of this molecule involves the coordinated action of various organs such as pancreas, liver and brain. Any disruption of this physiological balance may result in a dangerous compromise of general metabolic activities increasing the possibility of developing T1DM, T2DM and possibly AD. Astrocytes convert glucose into lactate and transfer it to neurons. This lactate is essential for neuronal metabolism and for various processes including the formation of synapses, dendrites and the expression of genes involved in memory. The brain is highly susceptible to variations in glucose blood levels, and both hypoglycemia and hyperglycemia can be dangerous. Pathological hyperglycemia induces changes in plasmatic osmotic pressure, mitochondrial production of free radicals, oxidative stress and activation of neuronal apoptosis, among others. Both AD and diabetes are chronic diseases having age as an important risk factor. As the brain ages, it seems to become much more susceptible to cellular damage induced by excess of circulating glucose and this could explain the appearance of cognitive changes observed in some patients with diabetes. Excessive circulation of pro-inflammatory agents has been observed in insulin resistance and is likely that some of these mediators may cross the bloodbrain barrier and induce abnormal neuroinflammation. GSK-3 is overexpressed in diabetes and also has been reported to regulate tau phosphorylation and production of A peptides in the brain. Currently, diabetes (hyperglycemia) is considered as a risk factor for the de- velopment of AD. A novel therapeutic approach, using intranasal insulin and anti-diabetic medications in patients suffering from AD is being explored and is discussed in this review.

UR - http://www.scopus.com/inward/record.url?scp=84958552684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958552684&partnerID=8YFLogxK

M3 - Article

C2 - 26648470

AN - SCOPUS:84958552684

VL - 22

SP - 812

EP - 818

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 7

ER -